Steven JD - AVROBIO Chief Secretary
| AVRODelisted Stock | USD 1.40 0.04 2.78% |
Executive
Steven JD is Chief Secretary of AVROBIO
| Age | 62 |
| Phone | 617 914 8420 |
| Web | https://www.avrobio.com |
AVROBIO Management Efficiency
The company has return on total asset (ROA) of (0.3518) % which means that it has lost $0.3518 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4273 %, meaning that it created $0.4273 on every $100 dollars invested by stockholders. AVROBIO's management efficiency ratios could be used to measure how well AVROBIO manages its routine affairs as well as how well it operates its assets and liabilities.AVROBIO currently holds 878 K in liabilities with Debt to Equity (D/E) ratio of 0.13, which may suggest the company is not taking enough advantage from borrowing. AVROBIO has a current ratio of 10.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about AVROBIO's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Sweeney | Ocean Biomedical | 59 | |
| John SullivanBolyai | Hepion Pharmaceuticals | 76 | |
| Kimberly Davis | Zura Bio Limited | 56 | |
| Biren Shah | Elevation Oncology | N/A | |
| Michael Howell | Zura Bio Limited | 47 | |
| Kevin CPA | Enveric Biosciences | 60 | |
| Candice Masse | Elevation Oncology | N/A | |
| Theresa Lowry | Zura Bio Limited | 50 | |
| Robert Yang | Elevation Oncology | N/A | |
| John Cavan | Hepion Pharmaceuticals | 66 | |
| David Brady | Zura Bio Limited | N/A | |
| Verender Badial | Zura Bio Limited | 52 | |
| Esq CPA | Ocean Biomedical | 59 | |
| Kiran MBBS | Zura Bio Limited | 51 | |
| MD MBA | Ocean Biomedical | 59 | |
| Daniel Trepanier | Hepion Pharmaceuticals | N/A | |
| Gary Whale | Zura Bio Limited | 50 | |
| Patrick Mayo | Hepion Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | 0.43 | |||
| Return On Asset | -0.35 |
AVROBIO Leadership Team
Elected by the shareholders, the AVROBIO's board of directors comprises two types of representatives: AVROBIO inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AVROBIO. The board's role is to monitor AVROBIO's management team and ensure that shareholders' interests are well served. AVROBIO's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AVROBIO's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Monique Silva, Sr Communications | ||
| Deanna MBA, Chief Officer | ||
| Geoff BSc, President, Founder | ||
| Steven JD, Chief Secretary | ||
| Andreas Kouri, Senior Manufacturing | ||
| MD FFPM, Chief Officer | ||
| Erik MBA, Interim President | ||
| Kirsten Dupuis, Chief Staff | ||
| Azadeh Golipour, Chief Officer | ||
| Matthew Arnold, Head Operations | ||
| Jeffrey Medin, Scientific Founder | ||
| Scott Gottesman, Vice Resource |
AVROBIO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AVROBIO a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.43 | |||
| Return On Asset | -0.35 | |||
| Current Valuation | (26.51 M) | |||
| Shares Outstanding | 44.89 M | |||
| Shares Owned By Insiders | 1.65 % | |||
| Shares Owned By Institutions | 68.80 % | |||
| Number Of Shares Shorted | 139.56 K | |||
| Price To Earning | (4.11) X | |||
| Price To Book | 0.60 X | |||
| EBITDA | (71.05 M) |
Pair Trading with AVROBIO
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AVROBIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will appreciate offsetting losses from the drop in the long position's value.Moving against AVROBIO Stock
| 0.87 | HYMTF | Hyundai Motor | PairCorr |
| 0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.81 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.77 | EC | Ecopetrol SA ADR | PairCorr |
| 0.75 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to AVROBIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AVROBIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AVROBIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AVROBIO to buy it.
The correlation of AVROBIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AVROBIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AVROBIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AVROBIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |